New Research Hub to Expand Biomedical Imaging Boundaries
Theranostics Australia, in collaboration with other respected industry partners, will work with PhD students and early career researchers on innovative projects at an $8.5m state-of-the-art research hub to be established at The University of Queensland (UQ).
The centre will provide firsthand training to the next generation of scientists, who will expand the boundaries of biomedical imaging to improve healthcare.
The Industrial Transformation Training Centre for Innovation in Biomedical Imaging Technology (CIBIT) will prepare new scientists to work in industry and develop ‘smart’ biotechnology and biomedical imaging techniques.
The UQ Centre for Advanced Imaging (CAI) Director, Professor David Reutens, said the $8.5m research will be funded by a $4.7m Australian Research Council (ARC) grant and $3.8m in cash and in-kind contributions from industry partners.
“It will play a leading role in the future of biomedical imaging,” he said.
“Biomedical imaging has been one of the most important advances in the history of medicine.
“It allows medical professionals to determine the location, nature and extent of disease with high accuracy and sensitivity, and has become an integral part of modern health care.
“This new centre will train industry-ready scientists to lead research into faster, more accurate and more cost-effective diagnostic imaging.”
The centre’s industry driven research will work to overcome barriers in the development and application of novel diagnostics, therapeutics and theranostics for important diseases like cancer.
Sixteen PhD students and five early career researchers will work on projects with industry partners.
The centre will involve researchers from across UQ, including the Centre for Advanced Imaging (CAI), UQ Business School (UQBS), the Australian Institute for Bioengineering and Nanotechnology (AIBN), the UQ Diamantina Institute (UQDI) and the School of Mathematics and Physics (UQSMP).
Industry partners include Siemens Healthcare Pty Ltd, Clarity Pharmaceuticals Pty Ltd, Minomic International Ltd, Inter-K Peptide Therapeutics Ltd, Theranostics Australia Pty Ltd, Beijing Genomics Institute, Brisbane Veterinary Specialists Centre, Uniting Care Medical Imaging, and Red Radiology Pty Ltd.
The centre builds upon previous investments in CAI and the National Imaging Facility (NIF) from the Queensland Government and the Commonwealth Government’s contributions to the NIF through the National Collaborative Research Infrastructure Strategy (NCRIS) and the Education Investment Fund (EIF).
Original Media Release by the University of Queensland: http://bit.ly/2toXaHR